Kane Biotech Inc. (TSXV: KNE)
Canada
· Delayed Price · Currency is CAD 0.110
-0.005 (-4.35%)
Nov 21, 2024, 9:43 AM EST
Kane Biotech Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 4.83 | -5.03 | -3.89 | -4.6 | -3.72 | -0.96 | Upgrade
|
| Depreciation & Amortization | 0.23 | 0.24 | 0.26 | 0.19 | 0.08 | 0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0 | 0.07 | 0.04 | 0.21 | Upgrade
|
| Stock-Based Compensation | 0.87 | 0.44 | 0.28 | 1.09 | 0.46 | 0.03 | Upgrade
|
| Other Operating Activities | 1.77 | 1.74 | 0.38 | -0.32 | -0.54 | 0.03 | Upgrade
|
| Change in Accounts Receivable | -0.31 | 0.01 | 0.46 | 0.04 | -0.28 | -0.25 | Upgrade
|
| Change in Inventory | -0.55 | -0.11 | -0.07 | -0.05 | 0.12 | -0.26 | Upgrade
|
| Change in Accounts Payable | 0.5 | 0.2 | -0.22 | 0.78 | 0.05 | 0.33 | Upgrade
|
| Change in Unearned Revenue | -0.43 | 0.55 | -0.09 | 0.51 | -0.07 | -0.07 | Upgrade
|
| Change in Other Net Operating Assets | -0 | -0.05 | 0.04 | 0.01 | -0.09 | -0.02 | Upgrade
|
| Operating Cash Flow | -5.8 | -3.22 | -3.04 | -2.29 | -3.94 | -0.89 | Upgrade
|
| Capital Expenditures | -0.02 | -0.01 | -0.01 | -0.19 | -0.03 | -0.02 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.05 | -0.04 | -0.07 | -0.17 | -0.1 | -0.07 | Upgrade
|
| Other Investing Activities | -0.51 | -0.07 | -0.03 | -0.02 | -0.04 | -0.07 | Upgrade
|
| Investing Cash Flow | 10.2 | -0.12 | -0.11 | -0.37 | -0.17 | -0.17 | Upgrade
|
| Short-Term Debt Issued | - | 2 | 2.1 | 1.1 | 1.48 | 1.05 | Upgrade
|
| Long-Term Debt Issued | - | 0.01 | 0.68 | 0.69 | 0.91 | 0.26 | Upgrade
|
| Total Debt Issued | 1 | 2.01 | 2.78 | 1.8 | 2.39 | 1.31 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.4 | -0.46 | -0.02 | -1.27 | Upgrade
|
| Long-Term Debt Repaid | - | -0.48 | -0.13 | -0.09 | -0.02 | -0 | Upgrade
|
| Total Debt Repaid | -6.65 | -0.48 | -0.53 | -0.55 | -0.04 | -1.27 | Upgrade
|
| Net Debt Issued (Repaid) | -5.65 | 1.53 | 2.25 | 1.25 | 2.35 | 0.04 | Upgrade
|
| Issuance of Common Stock | 0.42 | 0.42 | 0.97 | 1.12 | 0.7 | 1.6 | Upgrade
|
| Other Financing Activities | -0.44 | 1.04 | -0.12 | 0.45 | 1.23 | 0.18 | Upgrade
|
| Financing Cash Flow | -5.68 | 2.98 | 3.1 | 2.81 | 4.28 | 1.81 | Upgrade
|
| Net Cash Flow | -1.28 | -0.36 | -0.05 | 0.15 | 0.17 | 0.76 | Upgrade
|
| Free Cash Flow | -5.82 | -3.23 | -3.05 | -2.48 | -3.97 | -0.91 | Upgrade
|
| Free Cash Flow Margin | -769.03% | -2168.64% | -1947.70% | -153.99% | -295.64% | -53.69% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.03 | -0.02 | -0.04 | -0.01 | Upgrade
|
| Cash Interest Paid | 1.05 | 0.26 | 0.62 | 0.05 | - | 0.1 | Upgrade
|
| Levered Free Cash Flow | -1.98 | -1.45 | -2.63 | -1.48 | -2.95 | -2.4 | Upgrade
|
| Unlevered Free Cash Flow | -1.37 | -0.69 | -2.12 | -1.22 | -2.87 | -2.31 | Upgrade
|
| Change in Net Working Capital | -0.42 | -0.77 | 0.41 | -0.86 | 0.68 | 0.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.